Revenue | Over $500 million See Exact Annual Revenue |
---|---|
Employees | N/AExact Company Size |
Primary Industry | 3254 Pharmaceutical & Medicine Manufacturing |
Address | 2275 Half Day Rd Ste 200 Deerfield, IL 60015 avexisbio.com |
Novartis Gene Therapies | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
---|---|---|---|
2023 | Details in Premium Report | ||
2022 | |||
2021 | |||
2020 | |||
2019 |
1-Year Growth Rate: 3-Year Growth Rate (CAGR): |
$ Millions (Industry Average) | |
---|---|
Novartis Gene Therapies Revenue (Sales) | |
Cost of Goods Sold | |
Gross Profit | |
Operating Expenses | |
Advertising | |
Salaries and wages | |
Other Operating Expenses | |
Total Operating Expenses | |
Operating Income | |
EBITDA | |
EBIT (Earnings Before Interest and Taxes) | |
Net Profit | |
Trademark | Date |
---|---|
ONEGENE PROGRAM Providing information regarding insurance coverage and reimbursement for prescription drugs; financial administration of a patient assistance program for providing prescription drugs at reduced cost | 09/20/2019 |
ONREPLA Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparation in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression | 11/06/2017 |
GENREPLA Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparation in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression | 11/06/2017 |
Publisher: AnythingResearch
Company | Headquarters | Revenue ($ MM) |
---|---|---|
PFIZER | New York, NY | 100 |
ABBOTT LABORATORIES | Abbott Park, IL | 91 |
BRISTOL-MYERS SQUIBB | Princeton, NJ | 86 |
MERCK SHARP & DOHME | Rahway, NJ | 66 |
ELI LILLY | Indianapolis, IN | 65 |
CSL BEHRING | King Of Prussia, PA | 64 |
CSLB HOLDINGS | King Of Prussia, PA | 63 |
MERCK | Rahway, NJ | 62 |
ALLERGAN | Chicago, IL | 61 |
Company | Headquarters | Revenue ($ MM) |
---|---|---|
ABBOTT LABORATORIES | Abbott Park, IL | 100 |
ASTELLAS US | Northbrook, IL | 11 |
FRESENIUS KABI | Lake Zurich, IL | 11 |
HOSPIRA | Lake Forest, IL | 10 |
HORIZON THERAPEUTICS USA | Deerfield, IL | 5 |
ABBOTT HEALTHCARE PUERTO RICO LTD. C/O ABBOTT LABORATORIES | Abbott Park, IL | 4 |
Company | Revenue ($ MM) |
---|---|
|